Literature DB >> 12237335

Regulation of mouse kappa opioid receptor gene expression by different 3'-untranslated regions and the effect of retinoic acid.

Xinli Hu1, Jing Bi, Horace H Loh, Li-Na Wei.   

Abstract

The mouse kappa opioid receptor (KOR) gene uses two functional polyadenylation signals, separated by a distance of approximately 2.2 kilobases (kb) in the 3'-end of the gene. As a result, two major groups of KOR transcripts, with sizes of approximately 1.6 and 3.8 kb, respectively, are detected in mouse tissues and P19 cells. Utilization of different poly(A) of the KOR gene produces KOR transcripts of different mRNA stability, transcription efficiency, and regulatability. Retinoic acid specifically suppresses the expression of KOR transcripts using the second poly(A) in P19 cells. A putative transcriptional enhancer region is present within the second 3'-untranslated region (3'-UTR). It is concluded that alternative polyadenylation of the mouse KOR transcripts results in differential regulation of KOR expression at both transcriptional and post-transcriptional levels. A negative regulatory pathway for KOR transcription involves a putative enhancer region in its 3'-UTR. KOR mRNAs using the second poly(A) is more stable than that using the first poly(A).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237335     DOI: 10.1124/mol.62.4.881

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

4.  Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors.

Authors:  Eunhae Kim; Amy L Clark; Alexi Kiss; Jason W Hahn; Robin Wesselschmidt; Carmine J Coscia; Mariana M Belcheva
Journal:  J Biol Chem       Date:  2006-09-01       Impact factor: 5.157

5.  Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.

Authors:  Vadim Yuferov; David Fussell; K Steven LaForge; David A Nielsen; Derek Gordon; Ann Ho; Suzanne M Leal; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenetics       Date:  2004-12

6.  Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation.

Authors:  S W Park; Y He; S G Ha; H H Loh; L-N Wei
Journal:  Neuroscience       Date:  2008-01-16       Impact factor: 3.590

7.  Polyadenylation site-specific differences in the activity of the neuronal βCstF-64 protein in PC-12 cells.

Authors:  Ganesh S Shankarling; Clinton C MacDonald
Journal:  Gene       Date:  2013-08-12       Impact factor: 3.688

8.  Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.

Authors:  Sateesh Kunigal; Moorthy P Ponnusamy; Navneet Momi; Surinder K Batra; Srikumar P Chellappan
Journal:  Mol Cancer       Date:  2012-04-26       Impact factor: 27.401

9.  Regulatory role of the 3' untranslated region (3'UTR) of rat 5' deiodinase (D1). effects on messenger RNA translation and stability.

Authors:  Omar Arroyo-Helguera; Carmen Mejía-Viggiano; Alfredo Varela-Echavarría; Marcos Cajero-Juárez; Carmen Aceves
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

10.  Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b.

Authors:  Qifang Wu; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.